Human Tumor Immunology (Course Code: M-136)

Human Tumor Immunology (Course Code: M-136)


Elective Course Description

Students will participate in the management of cancer patients and in clinical investigation concerned with the biologic therapy of cancer. The students will also be participating in laboratory research aimed at developing new means to treat cancer using immunotherapeutic approaches. The purpose of this elective is to expose students to translational research and its application in the clinical setting. The course of this elective largely depends on the student’s prior experience in immunology, cell biology or biochemistry and will be designed accordingly with the student’s goals in view. The program offers the opportunity for clinical as well as laboratory experience. Once the student is selected she/he will discuss with the course director to determine the relative amount of time spent in the clinic versus laboratory and the project she/he will be involved in. 

Learning Objectives

  1. Expose the students to research in tumor immunology and translational research.
  2. Expose the students to patient care in outpatient settings. 
  3. Expose students to clinical research.

Suggested Readings 

  1. How the Immune System Works (Lauren M. Sompayrac)
  2. The New Era of Cancer Immunotherapy: Manipulating T-Cell Activity to Overcome Malignancy. Adv Cancer Res. 2015; 128: 1-68
  3. Immune Checkpoint Blockade in Cancer Therapy. J Clin Oncol. 2015 Jun 10; 33 (17): 1974-82

For the program calendar, please see the elective module dates section of our website.